BioHarvest Sciences Statistics
Total Valuation
BHST has a market cap or net worth of $73.90 million. The enterprise value is $67.77 million.
| Market Cap | 73.90M |
| Enterprise Value | 67.77M |
Important Dates
The last earnings date was Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BHST has 22.67 million shares outstanding. The number of shares has increased by 15.55% in one year.
| Current Share Class | 22.67M |
| Shares Outstanding | 22.67M |
| Shares Change (YoY) | +15.55% |
| Shares Change (QoQ) | +12.29% |
| Owned by Insiders (%) | 14.43% |
| Owned by Institutions (%) | 7.50% |
| Float | 19.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.10 |
| Forward PS | 1.63 |
| PB Ratio | 3.21 |
| P/TBV Ratio | 3.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.96, with a Debt / Equity ratio of 0.61.
| Current Ratio | 2.96 |
| Quick Ratio | 2.44 |
| Debt / Equity | 0.61 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.89 |
Financial Efficiency
Return on equity (ROE) is -103.29% and return on invested capital (ROIC) is -13.35%.
| Return on Equity (ROE) | -103.29% |
| Return on Assets (ROA) | -9.86% |
| Return on Invested Capital (ROIC) | -13.35% |
| Return on Capital Employed (ROCE) | -15.81% |
| Weighted Average Cost of Capital (WACC) | 12.50% |
| Revenue Per Employee | $395,000 |
| Profits Per Employee | -$128,517 |
| Employee Count | 89 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 3.17 |
Taxes
In the past 12 months, BHST has paid $84,000 in taxes.
| Income Tax | 84,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.23% in the last 52 weeks. The beta is 1.34, so BHST's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | -53.23% |
| 50-Day Moving Average | 3.90 |
| 200-Day Moving Average | 5.97 |
| Relative Strength Index (RSI) | 36.66 |
| Average Volume (20 Days) | 21,914 |
Short Selling Information
The latest short interest is 71,513, so 0.32% of the outstanding shares have been sold short.
| Short Interest | 71,513 |
| Short Previous Month | 66,373 |
| Short % of Shares Out | 0.32% |
| Short % of Float | 0.37% |
| Short Ratio (days to cover) | 1.81 |
Income Statement
In the last 12 months, BHST had revenue of $35.16 million and -$11.44 million in losses. Loss per share was -$0.58.
| Revenue | 35.16M |
| Gross Profit | 20.92M |
| Operating Income | -5.69M |
| Pretax Income | -11.35M |
| Net Income | -11.44M |
| EBITDA | -5.20M |
| EBIT | -5.69M |
| Loss Per Share | -$0.58 |
Balance Sheet
The company has $20.17 million in cash and $14.04 million in debt, with a net cash position of $6.13 million or $0.27 per share.
| Cash & Cash Equivalents | 20.17M |
| Total Debt | 14.04M |
| Net Cash | 6.13M |
| Net Cash Per Share | $0.27 |
| Equity (Book Value) | 23.02M |
| Book Value Per Share | 1.02 |
| Working Capital | 18.74M |
Cash Flow
In the last 12 months, operating cash flow was -$7.18 million and capital expenditures -$2.26 million, giving a free cash flow of -$9.44 million.
| Operating Cash Flow | -7.18M |
| Capital Expenditures | -2.26M |
| Depreciation & Amortization | 493,000 |
| Net Borrowing | 1.26M |
| Free Cash Flow | -9.44M |
| FCF Per Share | -$0.42 |
Margins
Gross margin is 59.50%, with operating and profit margins of -16.19% and -32.54%.
| Gross Margin | 59.50% |
| Operating Margin | -16.19% |
| Pretax Margin | -32.30% |
| Profit Margin | -32.54% |
| EBITDA Margin | -14.78% |
| EBIT Margin | -16.19% |
| FCF Margin | n/a |
Dividends & Yields
BHST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.55% |
| Shareholder Yield | -15.55% |
| Earnings Yield | -15.48% |
| FCF Yield | -12.78% |
Analyst Forecast
The average price target for BHST is $12.75, which is 291.10% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.75 |
| Price Target Difference | 291.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 36.03% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 3, 2024. It was a reverse split with a ratio of 1:35.
| Last Split Date | Jun 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |